Do intentions lead to action? Results of a longitudinal study assessing determinants of Tdap vaccine uptake during pregnancy in Quebec, Canada.
Immunization
Knowledge, attitudes
Pertussis
Pregnancy
Public health
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
13 Jun 2022
13 Jun 2022
Historique:
received:
11
04
2022
accepted:
03
06
2022
entrez:
13
6
2022
pubmed:
14
6
2022
medline:
16
6
2022
Statut:
epublish
Résumé
In Canada, vaccination against pertussis (Tdap) during pregnancy has been recommended since 2018, with suboptimal uptake. We aimed to assess the determinants of intention and uptake of Tdap vaccine among pregnant women in Quebec. Participants (< 21 weeks of pregnancy) were recruited in four Quebec regions. Two online surveys were administered during pregnancy (< 21 weeks and > 35 weeks). One measured vaccination intention and the other assessed the actual decision. Questionnaires were informed by the Theory of Planned Behaviour (TPB). We used logistic multivariate analysis to identify determinants of Tdap vaccination uptake during pregnancy using responses to both questionnaires. A total of 741 women answered the first survey and 568 (76.7%), the second survey. In the first survey most participants intended to receive the Tdap vaccine during their pregnancy (76.3%) and in the second survey, 82.4% reported having been vaccinated against Tdap during their pregnancy. In multivariate analysis, the main determinants of vaccine uptake were: a recommendation from a healthcare provider (OR = 7.6), vaccine intention (OR = 6.12), social norms (or thinking that most pregnant women will be vaccinated (OR = 3.81), recruitment site (OR = 3.61 for General Family Medicine unit) perceived behavioral control (or low perceived barriers to access vaccination services, (OR = 2.32) and anticipated feeling of guilt if not vaccinated (OR = 2.13). Safety concerns were the main reason for not intending or not receiving the vaccine during pregnancy. We observed high vaccine acceptance and uptake of pertussis vaccine in pregnancy. The core components of the TPB (intention, social norms and perceived behavioral control) were all predictors of vaccine uptake, but our multivariate analysis also showed that other determinants were influential: being sufficiently informed about Tdap vaccination, not having vaccine safety concerns, and anticipated regret if unvaccinated. To ensure high vaccine acceptance and uptake in pregnancy, strong recommendations by trusted healthcare providers and ease of access to vaccination services remain instrumental.
Sections du résumé
BACKGROUND
BACKGROUND
In Canada, vaccination against pertussis (Tdap) during pregnancy has been recommended since 2018, with suboptimal uptake. We aimed to assess the determinants of intention and uptake of Tdap vaccine among pregnant women in Quebec.
METHODS
METHODS
Participants (< 21 weeks of pregnancy) were recruited in four Quebec regions. Two online surveys were administered during pregnancy (< 21 weeks and > 35 weeks). One measured vaccination intention and the other assessed the actual decision. Questionnaires were informed by the Theory of Planned Behaviour (TPB). We used logistic multivariate analysis to identify determinants of Tdap vaccination uptake during pregnancy using responses to both questionnaires.
RESULTS
RESULTS
A total of 741 women answered the first survey and 568 (76.7%), the second survey. In the first survey most participants intended to receive the Tdap vaccine during their pregnancy (76.3%) and in the second survey, 82.4% reported having been vaccinated against Tdap during their pregnancy. In multivariate analysis, the main determinants of vaccine uptake were: a recommendation from a healthcare provider (OR = 7.6), vaccine intention (OR = 6.12), social norms (or thinking that most pregnant women will be vaccinated (OR = 3.81), recruitment site (OR = 3.61 for General Family Medicine unit) perceived behavioral control (or low perceived barriers to access vaccination services, (OR = 2.32) and anticipated feeling of guilt if not vaccinated (OR = 2.13). Safety concerns were the main reason for not intending or not receiving the vaccine during pregnancy.
CONCLUSION
CONCLUSIONS
We observed high vaccine acceptance and uptake of pertussis vaccine in pregnancy. The core components of the TPB (intention, social norms and perceived behavioral control) were all predictors of vaccine uptake, but our multivariate analysis also showed that other determinants were influential: being sufficiently informed about Tdap vaccination, not having vaccine safety concerns, and anticipated regret if unvaccinated. To ensure high vaccine acceptance and uptake in pregnancy, strong recommendations by trusted healthcare providers and ease of access to vaccination services remain instrumental.
Identifiants
pubmed: 35698053
doi: 10.1186/s12884-022-04809-6
pii: 10.1186/s12884-022-04809-6
pmc: PMC9189261
doi:
Substances chimiques
Diphtheria-Tetanus-acellular Pertussis Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
477Informations de copyright
© 2022. The Author(s).
Références
J Obstet Gynaecol Can. 2019 Sep;41(9):1344-1355
pubmed: 30361161
Vaccine. 2014 Aug 6;32(36):4602-13
pubmed: 24996123
Vaccine. 2021 Sep 15;39(39):5532-5537
pubmed: 34426028
Vaccine. 2015 Nov 25;33(47):6420-9
pubmed: 26320417
Vaccine. 2015 Oct 5;33(41):5445-5451
pubmed: 26307234
Public Health. 2021 Jul;196:43-51
pubmed: 34144334
Hum Vaccin Immunother. 2014;10(12):3629-41
pubmed: 25668670
Qual Health Res. 2016 Feb;26(3):411-25
pubmed: 25711847
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Feb;58(2):174-81
pubmed: 25446313
Women Birth. 2020 Mar;33(2):145-152
pubmed: 30853352
Hum Vaccin Immunother. 2020 Nov 1;16(11):2789-2799
pubmed: 32271655
Lancet. 2014 Oct 25;384(9953):1521-8
pubmed: 25037990
Hum Vaccin Immunother. 2020 Sep 1;16(9):2131-2135
pubmed: 32242766
Vaccine. 2020 Jun 26;38(31):4805-4815
pubmed: 32499068
CMAJ Open. 2020 May 15;8(2):E377-E382
pubmed: 32414884
Can Commun Dis Rep. 2018 Mar 01;44(3-4):91-94
pubmed: 31007617
Ann Ig. 2022 Jun 15;34(4):358-374
pubmed: 35195239
Vaccine. 2020 Jul 14;38(33):5131-5138
pubmed: 32409135
Midwifery. 2021 Sep;100:103062
pubmed: 34198208
Soc Sci Med. 2014 Jul;112:1-11
pubmed: 24788111
Int J Gynaecol Obstet. 2001 Nov;75 Suppl 1:S5-S23
pubmed: 11742639
CMAJ Open. 2022 Feb 1;10(1):E56-E63
pubmed: 35105682
Hum Vaccin Immunother. 2015;11(3):713-8
pubmed: 25714987
BMJ Open. 2021 Jun 21;11(6):e046545
pubmed: 34155074
Prev Med. 2019 Oct;127:105798
pubmed: 31404569
PLoS One. 2020 Jul 9;15(7):e0234827
pubmed: 32645112
J Pediatric Infect Dis Soc. 2020 Apr 30;9(2):118-127
pubmed: 30535079